Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 373 of 373 entries
View as:

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa

Phase: N/A Priority: Normal
NCT ID: NCT04143061 Org: User:
Start: 12/30/19 End: 01/28/23 Due: 01/28/24

Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

Phase: N/A Priority: Normal
NCT ID: NCT00258856 Org: User:
Start: 01/31/06 End: 11/30/07 Due: 11/30/08

Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

Phase: N/A Priority: Normal
NCT ID: NCT01900444 Org: User:
Start: 07/11/13 End: 03/11/14 Due: 03/11/15

A Study of Influenza Virus Vaccines in Children and Adults

Phase: N/A Priority: Normal
NCT ID: NCT00988143 Org: User:
Start: 10/31/09 End: 03/31/10 Due: 03/31/11

Phase 2 Study of Safety, Tolerability, and Immunogenicity of Three Dose Levels of ACAM3000 Smallpox Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00466245 Org: User:
Start: 07/31/05 End: 06/30/06 Due: 06/30/07

36-Month Post-marketing Surveillance and Analysis of Menactra Vaccine in 2-10 Year Olds

Phase: N/A Priority: Normal
NCT ID: NCT00728260 Org: User:
Start: 07/31/05 End: 05/31/13 Due: 05/31/14

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT06237296 Org: User:
Start: 01/23/24 End: 02/11/25 Due: 02/11/26

Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26

Phase: N/A Priority: Normal
NCT ID: NCT00700713 Org: User:
Start: 06/30/08 End: 03/31/09 Due: 03/31/10

Immunogenicity and Safety of a Tetravalent Dengue Vaccine Booster Injection in Subjects Who Previously Completed a 3-dose Schedule

Phase: N/A Priority: Normal
NCT ID: NCT02824198 Org: User:
Start: 07/01/16 End: 01/18/19 Due: 01/18/20

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT02955797 Org: User:
Start: 02/24/17 End: 10/26/17 Due: 10/26/18

Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00561002 Org: User:
Start: 10/31/07 End: 06/30/08 Due: 06/30/09

Study of Quadrivalent Influenza Vaccine Among Children

Phase: N/A Priority: Normal
NCT ID: NCT01240746 Org: User:
Start: 11/30/10 End: 02/29/12 Due: 02/28/13

Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia

Phase: N/A Priority: Normal
NCT ID: NCT05011123 Org: User:
Start: 10/07/21 End: 04/23/27 Due: 04/23/28

Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations

Phase: N/A Priority: Normal
NCT ID: NCT01359449 Org: User:
Start: 05/31/11 End: 11/30/12 Due: 11/30/13

Descriptive, Post-marketing, Passive Surveillance Safety Study of ADACEL™ Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00258882 Org: User:
Start: 01/31/06 End: 12/31/12 Due: 12/31/13

Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia

Phase: N/A Priority: Normal
NCT ID: NCT01373281 Org: User:
Start: 06/03/11 End: 11/21/17 Due: 11/21/18

Immunogenicity of Two Dosages of Inactivated, Split-Virion Influenza Vaccine Given by an Alternate Route in the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00296829 Org: User:
Start: 01/31/06 End: 02/28/07 Due: 02/28/08

Retrospective Survey of Safety of Fourth Dose Pentacel® in Children

Phase: N/A Priority: Normal
NCT ID: NCT00772369 Org: User:
Start: 09/30/03 End: 04/30/05 Due: 04/30/06

A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly

Phase: N/A Priority: Normal
NCT ID: NCT00954798 Org: User:
Start: 08/31/09 End: 03/31/11 Due: 03/31/12

Study of DTwP-HepB-Hib-IPV (SHAN6™) Vaccine Administered Concomitantly With Routine Pediatric Vaccines to Healthy Infants and Toddlers in Thailand

Phase: N/A Priority: Normal
NCT ID: NCT04429295 Org: User:
Start: 06/28/20 End: 11/20/21 Due: 11/20/22

Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT00631995 Org: User:
Start: 04/30/08 End: 04/30/09 Due: 04/30/10

Study of a Respiratory Syncytial Virus Candidate Formulation in Adults Aged 60 Years and Older

Phase: N/A Priority: Normal
NCT ID: NCT06251024 Org: User:
Start: 04/02/24 End: 03/11/25 Due: 03/11/26

Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom

Phase: N/A Priority: Normal
NCT ID: NCT03632720 Org: User:
Start: 10/10/18 End: 12/05/22 Due: 12/05/23